Article
Impact of germline and somatic missense variations on drug binding sites.
The pharmacogenomics journal - 1 Mar 2017
Yan C, Pattabiraman N, Goecks J, Lam P, Nayak A, Pan Y, Torcivia-Rodriguez J, Voskanian A, Wan Q, Mazumder R
Abstract excerpt
Advancements in next-generation sequencing (NGS) technologies are generating a vast amount of data. This exacerbates the current challenge of translating NGS data into actionable clinical interpretations. We have comprehensively combined germline and somatic nonsynonymous single-nucleotide variations (nsSNVs) that affect drug binding sites in order to investigate their prevalence. The integrated data thus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
